Tadalafil – Denmark

Tadalafil – Denmark

On Jun 15, 2018, the Danish Maritime & Commercial High Court granted preliminary injunction against Sandoz’ generic product & rejected invalidity challenges.
As reported on “EP law blog”, the Court found that DK/EP 1173181 patent showed surprising effect that Tadalafil can be used daily and is effective at low doses with a minimum of side effects. The Court specifically found that the use of a unit dosage comprising 1 to 5 mg Tadalafil up to a maximum total dose of 5 mg daily would not have been obvious to the person skilled in the art in view of prior arts.
Thus, Court granted preliminary injunction against Sandoz’ 2.5mg & 5mg strengths but not for 10mg strength because Eli Lilly had not rendered it probable that sale of Sandoz’ 10 mg tablets constituted an indirect infringement.

Leave a Reply

Leave a Reply

Your email address will not be published.

Disclaimer
All content provided on this blog is for informational purposes only. By using the blog, you agree that the information on this blog does not constitute legal or other professional advice on author's or on his company's behalf.

Copyrights 2022 Pharma IP Circle. All Rights Reserved